[关键词]
[摘要]
小泛素相关修饰物(small ubiquitin related modifier,SUMO)化修饰是可逆蛋白翻译后修饰,通过共价结合底物调控蛋白稳定性、定位及转录活性,参与细胞分化、氧化应激应答等生理过程。近年研究表明SUMO通路紊乱参与白内障、年龄相关性黄斑变性、糖尿病视网膜病变等致盲眼病有关。本文简述SUMO分子体系与酶促循环,总结SUMO修饰对晶状体、视网膜关键转录因子与细胞稳态的调控作用,梳理其在常见眼病中的分子机制,分析现有研究短板,展望SUMO修饰作为眼病分子标志物与治疗靶点的应用价值,为眼病机制研究与新药研发提供理论依据。
[Key word]
[Abstract]
SUMOylation, a reversible post-translational protein modification involving small ubiquitin-related modifiers (SUMOs), regulates protein stability, localization, and transcriptional activity through covalent substrate binding, participating in physiological processes such as cell differentiation and oxidative stress response. Recent studies have demonstrated that dysregulation of the SUMO pathway is involved in blindness-related eye diseases such as cataract, age-related macular degeneration, and diabetic retinopathy. This article briefly summarizes the SUMO molecular system and enzymatic cycle, summarizes the regulatory role of SUMO modification on key transcription factors and cellular homeostasis in the lens and retina, outlines its molecular mechanisms in common eye diseases, analyzes existing research limitations, and prospects the application value of SUMOylation as a molecular marker and therapeutic target for eye diseases, providing a theoretical basis for eye disease mechanism research and new drug development.
[中图分类号]
[基金项目]
中国博士后科学基金,国家自然科学基金项目(面上项目,重点项目,重大项目)